FDA: Hospira recalls 25% Dextrose Injection

Editor's Note

The Food and Drug Administration (FDA) on April 24 announced the recall by Hospira (Lake Forest, Illinois) of one lot of 25% Dextrose Injection, USP, (infant) prefilled syringes because of the presence of particulate matter identified as human hair.

The affected lot is NDC: 0409-1775-10, Lot 58382EV, Expiry Date 10CT 2017.

Posted 04/24/2017] AUDIENCE: Pharmacy ISSUE: Hospira is voluntarily recalling one lot of 25% Dextrose Injection, USP, (Infant) pre-filled syringe to the hospital/user level due to the presence of particulate matter, identified as human hair, found within an internal sample syringe.